MNOV Q4 2023 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$69M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$5,492

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$499,060

Free Cash Flow

-$499,038

Stock-Based Comp.

-$237,405

Balance Sheet

Total Assets

$66M

Total Liabilities

$4M

Stockholders' Equity

$62M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5,492	$0	—
Operating Income	-$2M	-$3M	+22.9%
Net Income	-$2M	-$3M	+31.4%